Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group's Optum ...

CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Pfizer is the first big pharmaceutical company to reach an agreement with the Trump administration over most-favored nation drug pricing, a deal that lowers U.S. prices of certain medications and ...

Bristol Myers Squibb hasn’t splashed out as much money as some of its peers in the fast-growing field of antibody drug conjugate (ADC) cancer therapies, but the pharmaceutical giant just struck a deal ...

Withings Health Solutions, a company offering health monitoring devices, has added Ilant Health to its Obesity Care Management Partner Ecosystem. It also released its best practices for obesity ...

A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...

A gene therapy for hearing loss. A drug that helps people quit e-cigarettes or vaping. An anesthetic whose main ingredient will be manufactured in the U.S. These are among the first nine therapies ...

Patients who want to prevent swelling attacks caused by the rare disease hereditary angioedema can choose from among injectable drugs whose dosing schedules range from every two weeks to every two ...

From left to right: Moderator Michael Kalishman, chief venture officer, Sentara Health; Nick Culbertson, managing director, Techstars; Dr. Ngoc-Anh Nguyen, vice chair of research, Houston Methodist ...